SGLT2 Inhibitors Treatment Market - Top Companies and Manufacturers

Companies Dominating the SGLT2 Inhibitors Treatment Landscape

Novartis International AG

Company overview
Business strategy
Key product offerings
Financial performances
Key performance indicators
Risk analysis
Recent development
Regional presence
SWOT analysis

Boehringer Ingelheim GmbH
Janssen pharmaceuticals
GRUPO TECNIMEDE
Unichem Laboratories Ltd.
Edificio Bluepharma

Browse Key Market Insights with Data Illustration:

SGLT2 Inhibitors Treatment Market Size & Share, Growth Forecasts 2037

In the News

Astellas Pharma Inc., announced that selective SGLT2 inhibitor Suglat Tablets 25mg and 50mg Ipragliflozin L-Proline, “Suglat Tablets”) became available for the indication of type 2 diabetes in the Japanese market today.
AstraZeneca’s Forxiga (dapagliflozin) was approved in China to reduce the risk of cardiovascular (CV) death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction (HFrEF).

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of SGLT2 inhibitors treatment is evaluated at USD 7.44 billion.

The SGLT2 inhibitors treatment market size was valued at USD 6.42 billion in 2024 and is set to exceed USD 21.14 billion by 2037, registering over 9.6% CAGR during the forecast period i.e., between 2025-2037. Growing Concern for the Prevalence of diabetes mellitus will drive the market growth.

North America industry is predicted to account for largest revenue share of 32% by 2037, impelled by increasing prevalence of obesity and lifestyle changes in the region.

The major players in the market are Novartis International AG, Financial performancesBoehringer Ingelheim GmbH, Janssen pharmaceuticals, GRUPO TECNIMEDE, Unichem Laboratories Ltd., Edificio Bluepharma

SGLT2 Inhibitors Treatment Market - Top Companies and Manufacturers

Companies Dominating the SGLT2 Inhibitors Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the SGLT2 inhibitors treatment market?

What are the factors driving the SGLT2 inhibitors treatment landscape?

Which region held the largest SGLT2 inhibitors treatment industry share?

Who are the key players in the SGLT2 inhibitors treatment sector?